- published: 14 Jul 2008
- views: 150770
Create your page here
-
remove the playlistIntravitreal
- remove the playlistIntravitreal
back to playlist
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degeneration, and other eye diseases.
Author: James Folk, MD
University of Iowa
Department of Ophthalmology
Subscribe to our FREE newsletter http://www.medrounds.org/ophthalmology-pearls/
Purchase Dr. Folk's book "Protect Your Sight" on Amazon.com: http://www.amazon.com/dp/0976968908?tag=medrounpublic-20&camp;=0&creative;=0&linkCode;=as1&creativeASIN;=0976968908&adid;=0SSXF4K086RG4VCMKCFH&
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids.
- published: 28 Feb 2010
- views: 73387
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc.
Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by the breakdown of the central portion of the retina (the nerve layer part of your eye that works like the film in a camera to pick up the picture) called the macula. The macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc. There are two types of macular degeneration: dry and wet. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred or distorted vision. Without treatment, vision loss may be quick and severe. There are other eye conditions that cause loss of vision due to abnormal growth of blood vessels in the back of the eye. These can occur even in young patients, and include, but are not limited to, conditions such as high myopia (nearsightedness), histoplasmosis, angioid streaks, and eye injury. Sometimes there is no known reason for the abnormal blood vessels. Without treatment, vision loss may be quick and severe.
POSSIBLE BENEFITS AND OFF-LABEL STATUS
Avastin™ was not initially developed to treat your eye condition. Based upon the results of clinical trials that demonstrated its safety and effectiveness, Avastin™ was approved by the Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer. As a condition of approval, the manufacturer produced a label explaining the indications, risks, and benefits. The label explains that Avastin™ works by blocking a substance known as vascular endothelial growth factor or VEGF. Blocking or inhibiting VEGF helps prevent further growth of the blood vessels that the cancer needs to continue growing.
Once a device or medication is approved by the FDA, physicians may use it "off-label" for other purposes if they are well-informed about the product, base its use on firm scientific method and sound medical evidence, and maintain records of its use and effects. Ophthalmologists are using Avastin™ off-label to treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth of the abnormal vessels that cause these conditions. Some patients treated with Avastin™ had less fluid and more normal-appearing maculas, and their vision improved. Avastin™ is also used, therefore, to treat macular edema, or swelling of the macula.
Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked at Medical University of South Carolina, Charleston, SC, USA, University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Center at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. Dr. Pandey's book on Pediatric Cataract Surgery (Lippincott Williams & Wilkins, USA) remains the bestseller on this topic. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology.
Contact Details:
Dr. Suresh K Pandey, MS (PGIMER), ASF (USA)
Dr. Vidushi Sharma, MD (AIIMS), FRCS (UK)
SuVi Eye Institute & Research Centre, Kota, Rajasthan, India
Phone +91 744 2433575, +91 9351412449
E-mail: suvieye@gmail.com, www.suvieye.com
- published: 09 Apr 2011
- views: 81992
Basic description of an intravitreal injection from a patient's perspective.
For those with a condition called "central retinal vein occlusion" there is a support group discussion forum at: http://groups.google.com/group/crvo-support/topics
and Patient to patient notes for a quick start toward understanding CRVO:
https://sites.google.com/site/crvoquickstart/
"Real Life" - http://www.youtube.com/watch?v=h9pIbSs3ofw
https://sites.google.com/site/danmohlerbecominglove/
- published: 03 Oct 2008
- views: 40743
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
- published: 18 Dec 2013
- views: 15104
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended 1 mg vancomycin dose. Use of sterile surgical gloves and sterile drappings sheets are a must. It is essential to obtain informed written consent for intravitreal therapy. Scrub hands thoroughly and wear sterile surgical gloves. Prepare intravitreal injection in three tuberculin syringes based on which drugs option has chosen. The pupil should be dilated prior to intravitreal therapy. Topical anaesthetic agents such as xylocaine or proparacaine are necessary for intravitreal therapy. However, many ophthalmologists additionally use subconjunctival anaesthetic injections at the proposed site of intravitreal injection. In endophthalmitis peribulbar anaesthetic injection is very useful, as it provides post intravitreal injection analgesia for many hours. The most critical step pre-operatively, is to use 10% povidone iodine to clean the Eyelids and to irrigate the ocular surface and conjunctival sac. It is necessary to use a lid speculum to ensure that the eyelashes and margins of the Eyelids do not contaminate the syringe and needle during injection. Sterile gloves should be worn. Tuberculin syringes with 26 or 30 gauge needle are very useful for giving intravitreal injections. It is recommended that the conjunctiva be displaced slightly with a cotton bud prior to beginning the injection so that the conjunctival entry point is slightly separated from the scleral entry point. This allows a better wound seal post injection. The injection should be given 3.5mm from the limbus in a pseudophakic eye. An attempt may be made to aspirate by gentle suction some vitreous fluid through pars plana for bacteriological analysis. Often one is likely to fail to get fluid. The the needle must be withdrawn slowly letting the vitreous collagen clogging the needle to escape back without causing traction retinal tears. Take the syringe with 0.1ml drugs. Puncture the globe at pars plana ( 3.5-4mm behind the limbus). Slowly inject the content. Withdraw. Repeat same procedure with the with remaining two syringes with 0.1 ml of the solution. Please note, though it is possible to mix an antibiotic and dexamethasone, it is not advisable to mix two antibiotics in the syringe. In order that concentrated antibiotics do not settle on the Macula, one may use a Pillow during the procedure and Turn the head to the opposite side, immediately after the injections. After the injection the patient may maintain a Face down position for 10 to 15 mts for the antibiotics to move towards the anterior segment. Put a pad and bandage for at least an hour. Analgesic and a tablet of acetazolamide is optional. If improvement noted but not impressive: Repeat antibiotics & dexamethasone after 48 hours. Definition of Improvement: Improvement of vision, however small it may appear Reduction or disapperance of hypopyon after sitting up of 1 hour or more. Clearing of the AC,Consolidation of the fibrin exudates or shrinking of the pupillary membrane,Better red reflex, Reduction of pain , Decrease in lid edema & chemosis, if it was present, If No Improvement or Worsening in 48-72 hours.A repeat vitreous tap and injection of antibiotics plus a pars plana vitrectomy (if this was not originally done) should be considered. Complications of an intravitreal injection include Retinal detachment (0.0 -- 1.0% per patient); Significant vitreous haemorrhage (0.4% per patient).
Contact details: Dr Suresh K Pandey, MS (PGIMER), ASF (USA)
SuVi Eye Institute, Kota, INDIA, suvieye@gmail.com
For Eye Doctors/Ophthalmologists: We offer various hand-on training courses at SuVi Eye Institute, C 13 Talwandi, Kota, Rajasthan, India. For details please contact suvieye@gmail.com Website: www.suvieye.com; phacolasiktraining.com; Phone +91 9351412449, Phaco Training India, Lasik Laser Training India, Hand on Basic and Advanced Phaco Training India, Customized Lasik Refractive Surgery Training India, Training in Oculoplastic Surgery India, Retinal Lasers Training India, Dr Suresh K Pandey Kota India, Dr Vidushi Sharma Kota India, SuVi Eye Institute Lasik Laser Center Kota India, Medical Retina Training India, Dacryo-Cysto-Rhinostomy (DCR) Training India, C3R (Corneal Collagen Cross Linking with Riboflavin) for Keratoconus Training India, Suture-less Glue Free Pterigium Surgery Training India, Botulinum Toxin Training India, Pediatric Cataract Surgery Training India, Intravitreal Injection Training India, Glaucoma Surgery Training India, Strabismus Surgery Training India, SICS (Small Incision Cataract Surgery)Training India, Manual Phaco Training India, Training in Premium IOL (Multifocal, Toric, Accommodative) India, Phakic IOL, Implantable Contact Lens (ICL) Training India, Keratoprosthesis training India.
- published: 24 Jan 2012
- views: 10303
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications.
This video demonstrates the technique of preparation of anti-vegf medications for multiple usages which is unique to this channel as you may find the technique of injection at various sites elsewhere but rarely has anybody demonstrated the method of preparing them.
- published: 25 May 2014
- views: 1510
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
- published: 16 Jan 2014
- views: 5054
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India.
The procedure of IVTA should be carried out with meticulous aseptic precaution, preferably in the operating room. It is very easily carried out under topical anesthesia. A pre-injection single drop of Povidone-Iodine (5%) solution is applied to the eye followed by thorough cleaning of the eyelashes and application of a lid speculum. 0.5% proparacaine hydrochloride drops are applied topically. Alternatively, one could also apply cotton tip pledgets soaked in lignocaine hydrochloride (4%) to the injection site for a couple of minutes prior to the injection to decrease the discomfort. Preservative free triamcinolone acetonide in a single-use bottle (40 mg/ml, 1ml bottle, Aurocort, Aurolab, Madurai, India), is drawn into a 1-cc tuberculin syringe after cleansing the top of the bottle with an alcohol wipe. A separate 27 or 26 gauge needle is placed onto the syringe, which is then inverted to remove air bubbles. The excess triamcinolone is discarded till 0.1 ml (4 mg) remains in the syringe. The injection site is usually the inferotemporal quadrant to avoid drug deposition in front of the visual axis. The stab is given 3 mm from the limbus (in aphakic and pseudophakic patients) and 3.5 mm from the limbus in phakic patients to ensure against passage of the needle through the vitreous base. The needle is usually not introduced all the way to the hub. Using a single, purposeful continuous maneuver, the steroid is injected into the eye. The needle is removed simultaneously with the application of a cotton tipped applicator over its entry site to prevent regurgitation of the injected material. Indirect ophthalmoscopy to check for central retinal artery (CRA) pulsation and paracentesis (if CRA pulsation is present or the globe feels very tense) are carried out, a drop of topical antibiotic solution is administered and the eye is patched. The patient is usually put on a post-injection course of topical antibiotic eye drops for a week.
About Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked in University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Cente at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology. Dr. Pandey can be reached at Suvi Eye Institute and Research Center, C 13 Talwandi, Kota, Rajasthan, India; E-mail- suvieye@gmail.com, www.suvieye.com
- published: 26 Oct 2010
- views: 21705
Intravitreal administration
Intravitreal is a route of administration of a drug or other substance, in which the substance is delivered into the eye. "Intravitreal" literally means "inside the eye"
Usually intravitreal administration of drugs is used to treat various conditions of the eye.
The following methods are known.
- Intravitreal depot injection
See also
References
External links
This page contains text from Wikipedia, the Free Encyclopedia -
http://wn.com/Intravitreal_administration
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
3:07Intravitreal Injection Technique
Intravitreal Injection TechniqueIntravitreal Injection Technique
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degeneration, and other eye diseases. Author: James Folk, MD University of Iowa Department of Ophthalmology Subscribe to our FREE newsletter http://www.medrounds.org/ophthalmology-pearls/ Purchase Dr. Folk's book "Protect Your Sight" on Amazon.com: http://www.amazon.com/dp/0976968908?tag=medrounpublic-20&camp;=0&creative;=0&linkCode;=as1&creativeASIN;=0976968908&adid;=0SSXF4K086RG4VCMKCFH& -
2:47Intravitreal eye injection
Intravitreal eye injectionIntravitreal eye injection
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids. -
2:09Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpgIntravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc. Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent. Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by the breakdown of the central portion of the retina (the nerve layer part of your eye that works like the film in a camera to pick up the picture) called the macula. The macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc. There are two types of macular degeneration: dry and wet. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred or distorted vision. Without treatment, vision loss may be quick and severe. There are other eye conditions that cause loss of vision due to abnormal growth of blood vessels in the back of the eye. These can occur even in young patients, and include, but are not limited to, conditions such as high myopia (nearsightedness), histoplasmosis, angioid streaks, and eye injury. Sometimes there is no known reason for the abnormal blood vessels. Without treatment, vision loss may be quick and severe. POSSIBLE BENEFITS AND OFF-LABEL STATUS Avastin™ was not initially developed to treat your eye condition. Based upon the results of clinical trials that demonstrated its safety and effectiveness, Avastin™ was approved by the Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer. As a condition of approval, the manufacturer produced a label explaining the indications, risks, and benefits. The label explains that Avastin™ works by blocking a substance known as vascular endothelial growth factor or VEGF. Blocking or inhibiting VEGF helps prevent further growth of the blood vessels that the cancer needs to continue growing. Once a device or medication is approved by the FDA, physicians may use it "off-label" for other purposes if they are well-informed about the product, base its use on firm scientific method and sound medical evidence, and maintain records of its use and effects. Ophthalmologists are using Avastin™ off-label to treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth of the abnormal vessels that cause these conditions. Some patients treated with Avastin™ had less fluid and more normal-appearing maculas, and their vision improved. Avastin™ is also used, therefore, to treat macular edema, or swelling of the macula. Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked at Medical University of South Carolina, Charleston, SC, USA, University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Center at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. Dr. Pandey's book on Pediatric Cataract Surgery (Lippincott Williams & Wilkins, USA) remains the bestseller on this topic. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology. Contact Details: Dr. Suresh K Pandey, MS (PGIMER), ASF (USA) Dr. Vidushi Sharma, MD (AIIMS), FRCS (UK) SuVi Eye Institute & Research Centre, Kota, Rajasthan, India Phone +91 744 2433575, +91 9351412449 E-mail: suvieye@gmail.com, www.suvieye.com -
5:07What is an Intravitreal Injection?
What is an Intravitreal Injection?What is an Intravitreal Injection?
Basic description of an intravitreal injection from a patient's perspective. For those with a condition called "central retinal vein occlusion" there is a support group discussion forum at: http://groups.google.com/group/crvo-support/topics and Patient to patient notes for a quick start toward understanding CRVO: https://sites.google.com/site/crvoquickstart/ "Real Life" - http://www.youtube.com/watch?v=h9pIbSs3ofw https://sites.google.com/site/danmohlerbecominglove/ -
3:36Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MDDexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema -
4:00Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpgIntravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended 1 mg vancomycin dose. Use of sterile surgical gloves and sterile drappings sheets are a must. It is essential to obtain informed written consent for intravitreal therapy. Scrub hands thoroughly and wear sterile surgical gloves. Prepare intravitreal injection in three tuberculin syringes based on which drugs option has chosen. The pupil should be dilated prior to intravitreal therapy. Topical anaesthetic agents such as xylocaine or proparacaine are necessary for intravitreal therapy. However, many ophthalmologists additionally use subconjunctival anaesthetic injections at the proposed site of intravitreal injection. In endophthalmitis peribulbar anaesthetic injection is very useful, as it provides post intravitreal injection analgesia for many hours. The most critical step pre-operatively, is to use 10% povidone iodine to clean the Eyelids and to irrigate the ocular surface and conjunctival sac. It is necessary to use a lid speculum to ensure that the eyelashes and margins of the Eyelids do not contaminate the syringe and needle during injection. Sterile gloves should be worn. Tuberculin syringes with 26 or 30 gauge needle are very useful for giving intravitreal injections. It is recommended that the conjunctiva be displaced slightly with a cotton bud prior to beginning the injection so that the conjunctival entry point is slightly separated from the scleral entry point. This allows a better wound seal post injection. The injection should be given 3.5mm from the limbus in a pseudophakic eye. An attempt may be made to aspirate by gentle suction some vitreous fluid through pars plana for bacteriological analysis. Often one is likely to fail to get fluid. The the needle must be withdrawn slowly letting the vitreous collagen clogging the needle to escape back without causing traction retinal tears. Take the syringe with 0.1ml drugs. Puncture the globe at pars plana ( 3.5-4mm behind the limbus). Slowly inject the content. Withdraw. Repeat same procedure with the with remaining two syringes with 0.1 ml of the solution. Please note, though it is possible to mix an antibiotic and dexamethasone, it is not advisable to mix two antibiotics in the syringe. In order that concentrated antibiotics do not settle on the Macula, one may use a Pillow during the procedure and Turn the head to the opposite side, immediately after the injections. After the injection the patient may maintain a Face down position for 10 to 15 mts for the antibiotics to move towards the anterior segment. Put a pad and bandage for at least an hour. Analgesic and a tablet of acetazolamide is optional. If improvement noted but not impressive: Repeat antibiotics & dexamethasone after 48 hours. Definition of Improvement: Improvement of vision, however small it may appear Reduction or disapperance of hypopyon after sitting up of 1 hour or more. Clearing of the AC,Consolidation of the fibrin exudates or shrinking of the pupillary membrane,Better red reflex, Reduction of pain , Decrease in lid edema & chemosis, if it was present, If No Improvement or Worsening in 48-72 hours.A repeat vitreous tap and injection of antibiotics plus a pars plana vitrectomy (if this was not originally done) should be considered. Complications of an intravitreal injection include Retinal detachment (0.0 -- 1.0% per patient); Significant vitreous haemorrhage (0.4% per patient). Contact details: Dr Suresh K Pandey, MS (PGIMER), ASF (USA) SuVi Eye Institute, Kota, INDIA, suvieye@gmail.com For Eye Doctors/Ophthalmologists: We offer various hand-on training courses at SuVi Eye Institute, C 13 Talwandi, Kota, Rajasthan, India. For details please contact suvieye@gmail.com Website: www.suvieye.com; phacolasiktraining.com; Phone +91 9351412449, Phaco Training India, Lasik Laser Training India, Hand on Basic and Advanced Phaco Training India, Customized Lasik Refractive Surgery Training India, Training in Oculoplastic Surgery India, Retinal Lasers Training India, Dr Suresh K Pandey Kota India, Dr Vidushi Sharma Kota India, SuVi Eye Institute Lasik Laser Center Kota India, Medical Retina Training India, Dacryo-Cysto-Rhinostomy (DCR) Training India, C3R (Corneal Collagen Cross Linking with Riboflavin) for Keratoconus Training India, Suture-less Glue Free Pterigium Surgery Training India, Botulinum Toxin Training India, Pediatric Cataract Surgery Training India, Intravitreal Injection Training India, Glaucoma Surgery Training India, Strabismus Surgery Training India, SICS (Small Incision Cataract Surgery)Training India, Manual Phaco Training India, Training in Premium IOL (Multifocal, Toric, Accommodative) India, Phakic IOL, Implantable Contact Lens (ICL) Training India, Keratoprosthesis training India. -
8:47Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NNAvastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications. This video demonstrates the technique of preparation of anti-vegf medications for multiple usages which is unique to this channel as you may find the technique of injection at various sites elsewhere but rarely has anybody demonstrated the method of preparing them. -
3:363D Dexamethasone Intravitreal Implant Ozurdex
3D Dexamethasone Intravitreal Implant Ozurdex3D Dexamethasone Intravitreal Implant Ozurdex
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema -
3:47Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
Intravitreal Injection Technique A Primer for Ophthalmology Resident and FellowsIntravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
-
0:48Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota IndiaIntravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India. The procedure of IVTA should be carried out with meticulous aseptic precaution, preferably in the operating room. It is very easily carried out under topical anesthesia. A pre-injection single drop of Povidone-Iodine (5%) solution is applied to the eye followed by thorough cleaning of the eyelashes and application of a lid speculum. 0.5% proparacaine hydrochloride drops are applied topically. Alternatively, one could also apply cotton tip pledgets soaked in lignocaine hydrochloride (4%) to the injection site for a couple of minutes prior to the injection to decrease the discomfort. Preservative free triamcinolone acetonide in a single-use bottle (40 mg/ml, 1ml bottle, Aurocort, Aurolab, Madurai, India), is drawn into a 1-cc tuberculin syringe after cleansing the top of the bottle with an alcohol wipe. A separate 27 or 26 gauge needle is placed onto the syringe, which is then inverted to remove air bubbles. The excess triamcinolone is discarded till 0.1 ml (4 mg) remains in the syringe. The injection site is usually the inferotemporal quadrant to avoid drug deposition in front of the visual axis. The stab is given 3 mm from the limbus (in aphakic and pseudophakic patients) and 3.5 mm from the limbus in phakic patients to ensure against passage of the needle through the vitreous base. The needle is usually not introduced all the way to the hub. Using a single, purposeful continuous maneuver, the steroid is injected into the eye. The needle is removed simultaneously with the application of a cotton tipped applicator over its entry site to prevent regurgitation of the injected material. Indirect ophthalmoscopy to check for central retinal artery (CRA) pulsation and paracentesis (if CRA pulsation is present or the globe feels very tense) are carried out, a drop of topical antibiotic solution is administered and the eye is patched. The patient is usually put on a post-injection course of topical antibiotic eye drops for a week. About Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked in University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Cente at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology. Dr. Pandey can be reached at Suvi Eye Institute and Research Center, C 13 Talwandi, Kota, Rajasthan, India; E-mail- suvieye@gmail.com, www.suvieye.com
-
Intravitreal Injection Technique
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degeneration, and other eye diseases. Author: James Folk, MD University of Iowa Department of Ophthalmology Subscribe to our FREE newsletter http://www.medrounds.org/ophthalmology-pearls/ Purchase Dr. Folk's book "Protect Your Sight" on Amazon.com: http://www.amazon.com/dp/0976968908?tag=medrounpublic-20&camp;=0&creative;=0&linkCode;=as1&creativeASIN;=0976968908&adid;=0SSXF4K086RG4VCMKCFH& -
Intravitreal eye injection
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids. -
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc. Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent. Age-related macular degeneration (AMD) is the leading cause of blindness in people ove... -
What is an Intravitreal Injection?
Basic description of an intravitreal injection from a patient's perspective. For those with a condition called "central retinal vein occlusion" there is a support group discussion forum at: http://groups.google.com/group/crvo-support/topics and Patient to patient notes for a quick start toward understanding CRVO: https://sites.google.com/site/crvoquickstart/ "Real Life" - http://www.youtube.com/watch?v=h9pIbSs3ofw https://sites.google.com/site/danmohlerbecominglove/ -
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema -
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended 1 mg vancomycin dose. Use of sterile surgical gloves and sterile drappings sheets are a must. It is essential to obtain informed written consent for intravitreal therapy. Scrub hands thoroughly and wear sterile surgical gloves. Prepare intravitreal injection in three tuberculin syringes based on which drugs option has chosen. The pupil should be dilated prior to intravitreal therapy. Topical anaesthetic agents such as xylocaine or proparacaine are necessary for intravitreal therapy. However, many ophthalmologists additionally use subconjunctival anaesthetic injections at the proposed site of intravitreal injection. In endophthalmit... -
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications. This video demonstrates the technique of preparation of anti-vegf medications for multiple usages which is unique to this channel as you may find the technique of injection at various sites elsewhere but rarely has anybody demonstrated the method of preparing them. -
3D Dexamethasone Intravitreal Implant Ozurdex
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema -
Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
-
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India. The procedure of IVTA should be carried out with meticulous aseptic precaution, preferably in the operating room. It is very easily carried out under topical anesthesia. A pre-injection single drop of Povidone-Iodine (5%) solution is applied to the eye followed by thorough cleaning of the eyelashes and application of a lid speculum. 0.5% proparacaine hydrochloride drops are applied topically. Alternatively, one could also apply cotton tip pledgets soaked in lignocaine hydrochloride (4%) to the injection site for a couple of minutes prior to the injection to decrease the discomfort. Preservative free triamcinolone acetonide in a single-use bot...
Intravitreal Injection Technique
- Order: Reorder
- Duration: 3:07
- Updated: 14 Jul 2008
- views: 150770
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degenerati...
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degeneration, and other eye diseases.
Author: James Folk, MD
University of Iowa
Department of Ophthalmology
Subscribe to our FREE newsletter http://www.medrounds.org/ophthalmology-pearls/
Purchase Dr. Folk's book "Protect Your Sight" on Amazon.com: http://www.amazon.com/dp/0976968908?tag=medrounpublic-20&camp;=0&creative;=0&linkCode;=as1&creativeASIN;=0976968908&adid;=0SSXF4K086RG4VCMKCFH&
wn.com/Intravitreal Injection Technique
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique used in endophthalmitis (a serious eye infection), macular degeneration, and other eye diseases.
Author: James Folk, MD
University of Iowa
Department of Ophthalmology
Subscribe to our FREE newsletter http://www.medrounds.org/ophthalmology-pearls/
Purchase Dr. Folk's book "Protect Your Sight" on Amazon.com: http://www.amazon.com/dp/0976968908?tag=medrounpublic-20&camp;=0&creative;=0&linkCode;=as1&creativeASIN;=0976968908&adid;=0SSXF4K086RG4VCMKCFH&
- published: 14 Jul 2008
- views: 150770
Intravitreal eye injection
- Order: Reorder
- Duration: 2:47
- Updated: 28 Feb 2010
- views: 73387
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids.
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids.
wn.com/Intravitreal Eye Injection
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, antibiotics or steroids.
- published: 28 Feb 2010
- views: 73387
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
- Order: Reorder
- Duration: 2:09
- Updated: 09 Apr 2011
- views: 81992
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal...
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc.
Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by the breakdown of the central portion of the retina (the nerve layer part of your eye that works like the film in a camera to pick up the picture) called the macula. The macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc. There are two types of macular degeneration: dry and wet. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred or distorted vision. Without treatment, vision loss may be quick and severe. There are other eye conditions that cause loss of vision due to abnormal growth of blood vessels in the back of the eye. These can occur even in young patients, and include, but are not limited to, conditions such as high myopia (nearsightedness), histoplasmosis, angioid streaks, and eye injury. Sometimes there is no known reason for the abnormal blood vessels. Without treatment, vision loss may be quick and severe.
POSSIBLE BENEFITS AND OFF-LABEL STATUS
Avastin™ was not initially developed to treat your eye condition. Based upon the results of clinical trials that demonstrated its safety and effectiveness, Avastin™ was approved by the Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer. As a condition of approval, the manufacturer produced a label explaining the indications, risks, and benefits. The label explains that Avastin™ works by blocking a substance known as vascular endothelial growth factor or VEGF. Blocking or inhibiting VEGF helps prevent further growth of the blood vessels that the cancer needs to continue growing.
Once a device or medication is approved by the FDA, physicians may use it "off-label" for other purposes if they are well-informed about the product, base its use on firm scientific method and sound medical evidence, and maintain records of its use and effects. Ophthalmologists are using Avastin™ off-label to treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth of the abnormal vessels that cause these conditions. Some patients treated with Avastin™ had less fluid and more normal-appearing maculas, and their vision improved. Avastin™ is also used, therefore, to treat macular edema, or swelling of the macula.
Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked at Medical University of South Carolina, Charleston, SC, USA, University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Center at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. Dr. Pandey's book on Pediatric Cataract Surgery (Lippincott Williams & Wilkins, USA) remains the bestseller on this topic. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology.
Contact Details:
Dr. Suresh K Pandey, MS (PGIMER), ASF (USA)
Dr. Vidushi Sharma, MD (AIIMS), FRCS (UK)
SuVi Eye Institute & Research Centre, Kota, Rajasthan, India
Phone +91 744 2433575, +91 9351412449
E-mail: suvieye@gmail.com, www.suvieye.com
wn.com/Intravitreal Injection On Anti Vegf Bevacizumab (Avastin) In A Case Of Macular Edema.Mpg
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc.
Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by the breakdown of the central portion of the retina (the nerve layer part of your eye that works like the film in a camera to pick up the picture) called the macula. The macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc. There are two types of macular degeneration: dry and wet. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred or distorted vision. Without treatment, vision loss may be quick and severe. There are other eye conditions that cause loss of vision due to abnormal growth of blood vessels in the back of the eye. These can occur even in young patients, and include, but are not limited to, conditions such as high myopia (nearsightedness), histoplasmosis, angioid streaks, and eye injury. Sometimes there is no known reason for the abnormal blood vessels. Without treatment, vision loss may be quick and severe.
POSSIBLE BENEFITS AND OFF-LABEL STATUS
Avastin™ was not initially developed to treat your eye condition. Based upon the results of clinical trials that demonstrated its safety and effectiveness, Avastin™ was approved by the Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer. As a condition of approval, the manufacturer produced a label explaining the indications, risks, and benefits. The label explains that Avastin™ works by blocking a substance known as vascular endothelial growth factor or VEGF. Blocking or inhibiting VEGF helps prevent further growth of the blood vessels that the cancer needs to continue growing.
Once a device or medication is approved by the FDA, physicians may use it "off-label" for other purposes if they are well-informed about the product, base its use on firm scientific method and sound medical evidence, and maintain records of its use and effects. Ophthalmologists are using Avastin™ off-label to treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth of the abnormal vessels that cause these conditions. Some patients treated with Avastin™ had less fluid and more normal-appearing maculas, and their vision improved. Avastin™ is also used, therefore, to treat macular edema, or swelling of the macula.
Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked at Medical University of South Carolina, Charleston, SC, USA, University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Center at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. Dr. Pandey's book on Pediatric Cataract Surgery (Lippincott Williams & Wilkins, USA) remains the bestseller on this topic. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology.
Contact Details:
Dr. Suresh K Pandey, MS (PGIMER), ASF (USA)
Dr. Vidushi Sharma, MD (AIIMS), FRCS (UK)
SuVi Eye Institute & Research Centre, Kota, Rajasthan, India
Phone +91 744 2433575, +91 9351412449
E-mail: suvieye@gmail.com, www.suvieye.com
- published: 09 Apr 2011
- views: 81992
What is an Intravitreal Injection?
- Order: Reorder
- Duration: 5:07
- Updated: 03 Oct 2008
- views: 40743
Basic description of an intravitreal injection from a patient's perspective.
For those with a condition called "central retinal vein occlusion" there is a suppo...
Basic description of an intravitreal injection from a patient's perspective.
For those with a condition called "central retinal vein occlusion" there is a support group discussion forum at: http://groups.google.com/group/crvo-support/topics
and Patient to patient notes for a quick start toward understanding CRVO:
https://sites.google.com/site/crvoquickstart/
"Real Life" - http://www.youtube.com/watch?v=h9pIbSs3ofw
https://sites.google.com/site/danmohlerbecominglove/
wn.com/What Is An Intravitreal Injection
Basic description of an intravitreal injection from a patient's perspective.
For those with a condition called "central retinal vein occlusion" there is a support group discussion forum at: http://groups.google.com/group/crvo-support/topics
and Patient to patient notes for a quick start toward understanding CRVO:
https://sites.google.com/site/crvoquickstart/
"Real Life" - http://www.youtube.com/watch?v=h9pIbSs3ofw
https://sites.google.com/site/danmohlerbecominglove/
- published: 03 Oct 2008
- views: 40743
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
- Order: Reorder
- Duration: 3:36
- Updated: 18 Dec 2013
- views: 15104
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
- published: 18 Dec 2013
- views: 15104
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
- Order: Reorder
- Duration: 4:00
- Updated: 24 Jan 2012
- views: 10303
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended...
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended 1 mg vancomycin dose. Use of sterile surgical gloves and sterile drappings sheets are a must. It is essential to obtain informed written consent for intravitreal therapy. Scrub hands thoroughly and wear sterile surgical gloves. Prepare intravitreal injection in three tuberculin syringes based on which drugs option has chosen. The pupil should be dilated prior to intravitreal therapy. Topical anaesthetic agents such as xylocaine or proparacaine are necessary for intravitreal therapy. However, many ophthalmologists additionally use subconjunctival anaesthetic injections at the proposed site of intravitreal injection. In endophthalmitis peribulbar anaesthetic injection is very useful, as it provides post intravitreal injection analgesia for many hours. The most critical step pre-operatively, is to use 10% povidone iodine to clean the Eyelids and to irrigate the ocular surface and conjunctival sac. It is necessary to use a lid speculum to ensure that the eyelashes and margins of the Eyelids do not contaminate the syringe and needle during injection. Sterile gloves should be worn. Tuberculin syringes with 26 or 30 gauge needle are very useful for giving intravitreal injections. It is recommended that the conjunctiva be displaced slightly with a cotton bud prior to beginning the injection so that the conjunctival entry point is slightly separated from the scleral entry point. This allows a better wound seal post injection. The injection should be given 3.5mm from the limbus in a pseudophakic eye. An attempt may be made to aspirate by gentle suction some vitreous fluid through pars plana for bacteriological analysis. Often one is likely to fail to get fluid. The the needle must be withdrawn slowly letting the vitreous collagen clogging the needle to escape back without causing traction retinal tears. Take the syringe with 0.1ml drugs. Puncture the globe at pars plana ( 3.5-4mm behind the limbus). Slowly inject the content. Withdraw. Repeat same procedure with the with remaining two syringes with 0.1 ml of the solution. Please note, though it is possible to mix an antibiotic and dexamethasone, it is not advisable to mix two antibiotics in the syringe. In order that concentrated antibiotics do not settle on the Macula, one may use a Pillow during the procedure and Turn the head to the opposite side, immediately after the injections. After the injection the patient may maintain a Face down position for 10 to 15 mts for the antibiotics to move towards the anterior segment. Put a pad and bandage for at least an hour. Analgesic and a tablet of acetazolamide is optional. If improvement noted but not impressive: Repeat antibiotics & dexamethasone after 48 hours. Definition of Improvement: Improvement of vision, however small it may appear Reduction or disapperance of hypopyon after sitting up of 1 hour or more. Clearing of the AC,Consolidation of the fibrin exudates or shrinking of the pupillary membrane,Better red reflex, Reduction of pain , Decrease in lid edema & chemosis, if it was present, If No Improvement or Worsening in 48-72 hours.A repeat vitreous tap and injection of antibiotics plus a pars plana vitrectomy (if this was not originally done) should be considered. Complications of an intravitreal injection include Retinal detachment (0.0 -- 1.0% per patient); Significant vitreous haemorrhage (0.4% per patient).
Contact details: Dr Suresh K Pandey, MS (PGIMER), ASF (USA)
SuVi Eye Institute, Kota, INDIA, suvieye@gmail.com
For Eye Doctors/Ophthalmologists: We offer various hand-on training courses at SuVi Eye Institute, C 13 Talwandi, Kota, Rajasthan, India. For details please contact suvieye@gmail.com Website: www.suvieye.com; phacolasiktraining.com; Phone +91 9351412449, Phaco Training India, Lasik Laser Training India, Hand on Basic and Advanced Phaco Training India, Customized Lasik Refractive Surgery Training India, Training in Oculoplastic Surgery India, Retinal Lasers Training India, Dr Suresh K Pandey Kota India, Dr Vidushi Sharma Kota India, SuVi Eye Institute Lasik Laser Center Kota India, Medical Retina Training India, Dacryo-Cysto-Rhinostomy (DCR) Training India, C3R (Corneal Collagen Cross Linking with Riboflavin) for Keratoconus Training India, Suture-less Glue Free Pterigium Surgery Training India, Botulinum Toxin Training India, Pediatric Cataract Surgery Training India, Intravitreal Injection Training India, Glaucoma Surgery Training India, Strabismus Surgery Training India, SICS (Small Incision Cataract Surgery)Training India, Manual Phaco Training India, Training in Premium IOL (Multifocal, Toric, Accommodative) India, Phakic IOL, Implantable Contact Lens (ICL) Training India, Keratoprosthesis training India.
wn.com/Intravitreal Injection Of Vancomycin Ceftazidime For Postop Endothalmitis Dr Suresh Pandey.Mpg
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Ceftazidime for Postoperative Endophthalmitis. The commonly recommended 1 mg vancomycin dose. Use of sterile surgical gloves and sterile drappings sheets are a must. It is essential to obtain informed written consent for intravitreal therapy. Scrub hands thoroughly and wear sterile surgical gloves. Prepare intravitreal injection in three tuberculin syringes based on which drugs option has chosen. The pupil should be dilated prior to intravitreal therapy. Topical anaesthetic agents such as xylocaine or proparacaine are necessary for intravitreal therapy. However, many ophthalmologists additionally use subconjunctival anaesthetic injections at the proposed site of intravitreal injection. In endophthalmitis peribulbar anaesthetic injection is very useful, as it provides post intravitreal injection analgesia for many hours. The most critical step pre-operatively, is to use 10% povidone iodine to clean the Eyelids and to irrigate the ocular surface and conjunctival sac. It is necessary to use a lid speculum to ensure that the eyelashes and margins of the Eyelids do not contaminate the syringe and needle during injection. Sterile gloves should be worn. Tuberculin syringes with 26 or 30 gauge needle are very useful for giving intravitreal injections. It is recommended that the conjunctiva be displaced slightly with a cotton bud prior to beginning the injection so that the conjunctival entry point is slightly separated from the scleral entry point. This allows a better wound seal post injection. The injection should be given 3.5mm from the limbus in a pseudophakic eye. An attempt may be made to aspirate by gentle suction some vitreous fluid through pars plana for bacteriological analysis. Often one is likely to fail to get fluid. The the needle must be withdrawn slowly letting the vitreous collagen clogging the needle to escape back without causing traction retinal tears. Take the syringe with 0.1ml drugs. Puncture the globe at pars plana ( 3.5-4mm behind the limbus). Slowly inject the content. Withdraw. Repeat same procedure with the with remaining two syringes with 0.1 ml of the solution. Please note, though it is possible to mix an antibiotic and dexamethasone, it is not advisable to mix two antibiotics in the syringe. In order that concentrated antibiotics do not settle on the Macula, one may use a Pillow during the procedure and Turn the head to the opposite side, immediately after the injections. After the injection the patient may maintain a Face down position for 10 to 15 mts for the antibiotics to move towards the anterior segment. Put a pad and bandage for at least an hour. Analgesic and a tablet of acetazolamide is optional. If improvement noted but not impressive: Repeat antibiotics & dexamethasone after 48 hours. Definition of Improvement: Improvement of vision, however small it may appear Reduction or disapperance of hypopyon after sitting up of 1 hour or more. Clearing of the AC,Consolidation of the fibrin exudates or shrinking of the pupillary membrane,Better red reflex, Reduction of pain , Decrease in lid edema & chemosis, if it was present, If No Improvement or Worsening in 48-72 hours.A repeat vitreous tap and injection of antibiotics plus a pars plana vitrectomy (if this was not originally done) should be considered. Complications of an intravitreal injection include Retinal detachment (0.0 -- 1.0% per patient); Significant vitreous haemorrhage (0.4% per patient).
Contact details: Dr Suresh K Pandey, MS (PGIMER), ASF (USA)
SuVi Eye Institute, Kota, INDIA, suvieye@gmail.com
For Eye Doctors/Ophthalmologists: We offer various hand-on training courses at SuVi Eye Institute, C 13 Talwandi, Kota, Rajasthan, India. For details please contact suvieye@gmail.com Website: www.suvieye.com; phacolasiktraining.com; Phone +91 9351412449, Phaco Training India, Lasik Laser Training India, Hand on Basic and Advanced Phaco Training India, Customized Lasik Refractive Surgery Training India, Training in Oculoplastic Surgery India, Retinal Lasers Training India, Dr Suresh K Pandey Kota India, Dr Vidushi Sharma Kota India, SuVi Eye Institute Lasik Laser Center Kota India, Medical Retina Training India, Dacryo-Cysto-Rhinostomy (DCR) Training India, C3R (Corneal Collagen Cross Linking with Riboflavin) for Keratoconus Training India, Suture-less Glue Free Pterigium Surgery Training India, Botulinum Toxin Training India, Pediatric Cataract Surgery Training India, Intravitreal Injection Training India, Glaucoma Surgery Training India, Strabismus Surgery Training India, SICS (Small Incision Cataract Surgery)Training India, Manual Phaco Training India, Training in Premium IOL (Multifocal, Toric, Accommodative) India, Phakic IOL, Implantable Contact Lens (ICL) Training India, Keratoprosthesis training India.
- published: 24 Jan 2012
- views: 10303
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
- Order: Reorder
- Duration: 8:47
- Updated: 25 May 2014
- views: 1510
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occ...
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications.
This video demonstrates the technique of preparation of anti-vegf medications for multiple usages which is unique to this channel as you may find the technique of injection at various sites elsewhere but rarely has anybody demonstrated the method of preparing them.
wn.com/Avastin Preparation And Intravitreal Injection Technique Dr Garima Lakhotia Nn
Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions. The frequency of intravitreal injections has significantly increased since the introduction of Anti-VEGF medications. This is an important procedure that Retina Specialists use on a daily basis, and it is important to master the techniques of effective injections for patient safety and reduction of complications.
This video demonstrates the technique of preparation of anti-vegf medications for multiple usages which is unique to this channel as you may find the technique of injection at various sites elsewhere but rarely has anybody demonstrated the method of preparing them.
- published: 25 May 2014
- views: 1510
3D Dexamethasone Intravitreal Implant Ozurdex
- Order: Reorder
- Duration: 3:36
- Updated: 16 Jan 2014
- views: 5054
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
- published: 16 Jan 2014
- views: 5054
Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
- Order: Reorder
- Duration: 3:47
- Updated: 31 May 2016
- views: 38
- published: 31 May 2016
- views: 38
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
- Order: Reorder
- Duration: 0:48
- Updated: 26 Oct 2010
- views: 21705
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India.
The proced...
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India.
The procedure of IVTA should be carried out with meticulous aseptic precaution, preferably in the operating room. It is very easily carried out under topical anesthesia. A pre-injection single drop of Povidone-Iodine (5%) solution is applied to the eye followed by thorough cleaning of the eyelashes and application of a lid speculum. 0.5% proparacaine hydrochloride drops are applied topically. Alternatively, one could also apply cotton tip pledgets soaked in lignocaine hydrochloride (4%) to the injection site for a couple of minutes prior to the injection to decrease the discomfort. Preservative free triamcinolone acetonide in a single-use bottle (40 mg/ml, 1ml bottle, Aurocort, Aurolab, Madurai, India), is drawn into a 1-cc tuberculin syringe after cleansing the top of the bottle with an alcohol wipe. A separate 27 or 26 gauge needle is placed onto the syringe, which is then inverted to remove air bubbles. The excess triamcinolone is discarded till 0.1 ml (4 mg) remains in the syringe. The injection site is usually the inferotemporal quadrant to avoid drug deposition in front of the visual axis. The stab is given 3 mm from the limbus (in aphakic and pseudophakic patients) and 3.5 mm from the limbus in phakic patients to ensure against passage of the needle through the vitreous base. The needle is usually not introduced all the way to the hub. Using a single, purposeful continuous maneuver, the steroid is injected into the eye. The needle is removed simultaneously with the application of a cotton tipped applicator over its entry site to prevent regurgitation of the injected material. Indirect ophthalmoscopy to check for central retinal artery (CRA) pulsation and paracentesis (if CRA pulsation is present or the globe feels very tense) are carried out, a drop of topical antibiotic solution is administered and the eye is patched. The patient is usually put on a post-injection course of topical antibiotic eye drops for a week.
About Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked in University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Cente at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology. Dr. Pandey can be reached at Suvi Eye Institute and Research Center, C 13 Talwandi, Kota, Rajasthan, India; E-mail- suvieye@gmail.com, www.suvieye.com
wn.com/Intravitreal Injection Of Triamcinolone Acetonide Dr Suresh K Pandey Suvi Eye Institute Kota India
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed by Dr Suresh K Pandey at Suvi Eye Institute, Kota, India.
The procedure of IVTA should be carried out with meticulous aseptic precaution, preferably in the operating room. It is very easily carried out under topical anesthesia. A pre-injection single drop of Povidone-Iodine (5%) solution is applied to the eye followed by thorough cleaning of the eyelashes and application of a lid speculum. 0.5% proparacaine hydrochloride drops are applied topically. Alternatively, one could also apply cotton tip pledgets soaked in lignocaine hydrochloride (4%) to the injection site for a couple of minutes prior to the injection to decrease the discomfort. Preservative free triamcinolone acetonide in a single-use bottle (40 mg/ml, 1ml bottle, Aurocort, Aurolab, Madurai, India), is drawn into a 1-cc tuberculin syringe after cleansing the top of the bottle with an alcohol wipe. A separate 27 or 26 gauge needle is placed onto the syringe, which is then inverted to remove air bubbles. The excess triamcinolone is discarded till 0.1 ml (4 mg) remains in the syringe. The injection site is usually the inferotemporal quadrant to avoid drug deposition in front of the visual axis. The stab is given 3 mm from the limbus (in aphakic and pseudophakic patients) and 3.5 mm from the limbus in phakic patients to ensure against passage of the needle through the vitreous base. The needle is usually not introduced all the way to the hub. Using a single, purposeful continuous maneuver, the steroid is injected into the eye. The needle is removed simultaneously with the application of a cotton tipped applicator over its entry site to prevent regurgitation of the injected material. Indirect ophthalmoscopy to check for central retinal artery (CRA) pulsation and paracentesis (if CRA pulsation is present or the globe feels very tense) are carried out, a drop of topical antibiotic solution is administered and the eye is patched. The patient is usually put on a post-injection course of topical antibiotic eye drops for a week.
About Dr Suresh K Pandey- A medical graduate of Rani Durgawati University, Medical College, Jabalpur, M.P., India; Dr. Pandey completed his residency in Ophthalmology from prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked in University of Utah, USA & University of Sydney, Australia from1998 to 2006. Dr. Pandey returned to India in 2006 to establish SuVi Eye Institute and Research Cente at Kota, Rajasthan, India (www.suvieye.com). Dr. Pandey has presented more than 150 scientific papers in various international ophthalmological meetings and authored more than 100 scientific papers/communications, 50 textbook chapters, and 10 ophthalmic textbooks. In 2005, Dr. Pandey was invited to demonstrate Live Surgery at international meeting at Milan, Italy. Dr. Pandey received several prestigious awards for his research & surgical innovations, which include Best-of-Show Video Award, Best Poster Award, Best-Paper-of-the-Session Award for the surgical videos, scientific posters and papers in the national and international ophthalmology congresses. Most recently, Dr. Pandey has been selected for Achievement Award by the American Academy of Ophthalmology. Dr. Pandey can be reached at Suvi Eye Institute and Research Center, C 13 Talwandi, Kota, Rajasthan, India; E-mail- suvieye@gmail.com, www.suvieye.com
- published: 26 Oct 2010
- views: 21705
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
3:07
Intravitreal Injection Technique
http://www.eyepodvideo.org Instructional video explaining intravitreal injection technique...
published: 14 Jul 2008
Intravitreal Injection Technique
Intravitreal Injection Technique
- Report rights infringement
- published: 14 Jul 2008
- views: 150770
2:47
Intravitreal eye injection
Intraocular injection into the vitreal cavity for the delivery of anti-VEGF medication, an...
published: 28 Feb 2010
Intravitreal eye injection
Intravitreal eye injection
- Report rights infringement
- published: 28 Feb 2010
- views: 73387
2:09
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
In this video Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, ...
published: 09 Apr 2011
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg
- Report rights infringement
- published: 09 Apr 2011
- views: 81992
5:07
What is an Intravitreal Injection?
Basic description of an intravitreal injection from a patient's perspective.
For those wit...
published: 03 Oct 2008
What is an Intravitreal Injection?
What is an Intravitreal Injection?
- Report rights infringement
- published: 03 Oct 2008
- views: 40743
3:36
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
published: 18 Dec 2013
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
Dexamethasone Intravitreal Implant Ozurdex implantation, by A. John Kanellopoulos, MD
- Report rights infringement
- published: 18 Dec 2013
- views: 15104
4:00
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
In this video, we describe pearls for preparing intravitreal Injection of Vancomycin & Cef...
published: 24 Jan 2012
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
Intravitreal Injection of Vancomycin & Ceftazidime for Postop Endothalmitis Dr Suresh Pandey.mpg
- Report rights infringement
- published: 24 Jan 2012
- views: 10303
8:47
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
Intravitreal drug delivery has become a popular method of treatment of many retinal diseas...
published: 25 May 2014
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
Avastin preparation and intravitreal injection technique Dr Garima Lakhotia NN
- Report rights infringement
- published: 25 May 2014
- views: 1510
3:36
3D Dexamethasone Intravitreal Implant Ozurdex
Dexamethasone Intravitreal Implant - Ozurdex - for Chronic Macula edema
published: 16 Jan 2014
3D Dexamethasone Intravitreal Implant Ozurdex
3D Dexamethasone Intravitreal Implant Ozurdex
- Report rights infringement
- published: 16 Jan 2014
- views: 5054
3:47
Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
published: 31 May 2016
Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
Intravitreal Injection Technique A Primer for Ophthalmology Resident and Fellows
- Report rights infringement
- published: 31 May 2016
- views: 38
0:48
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
This video illustrate Intravitreal Injection of Triamcinolone Acetonide (IVTA) performed ...
published: 26 Oct 2010
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
Intravitreal Injection of Triamcinolone Acetonide Dr Suresh K Pandey SuVi Eye Institute Kota India
- Report rights infringement
- published: 26 Oct 2010
- views: 21705
Intravitreal Injection Technique...
Intravitreal eye injection...
Intravitreal Injection on Anti-VEGF Bevacizumab (A...
What is an Intravitreal Injection?...
Dexamethasone Intravitreal Implant Ozurdex implant...
Intravitreal Injection of Vancomycin & Ceftazidime...
Avastin preparation and intravitreal injection tec...
3D Dexamethasone Intravitreal Implant Ozurdex...
Intravitreal Injection Technique A Primer for Oph...
Intravitreal Injection of Triamcinolone Acetonide ...
photo: AP / J. Scott Applewhite
Social Media Question Existence Of Trump Speechwriter Meredith McIver
Edit WorldNews.com 20 Jul 2016
And Melania Trump's 2016 RNC speech isn't the only high-profile writing she's created.McIver was a co-author on a number of Donald Trump's books, including the 2004 bestseller "How to Get Rich," the New York Daily News reported.The paper said McIver is a 65-year-old Manhattan resident and registered Democrat....
photo: AP / Carolyn Kaster
Report: Author of Melania Trump Speech May Have Violated Campaign Finance Laws
Edit WorldNews.com 20 Jul 2016
“On the face of it, this looks like a corporate violation.” That is “a violation of federal law. It can result in civil penalties to the corporation and the campaign.” – Lawrence Noble, general counsel for the Campaign Legal Center ... She’s has worked for Trump since 2011 as a staff writer. She helped write such books as Trump. How to Get Rich....
photo: WN
[VIDEO]: UFO Or Puppet? Alien Hunters Believe Creature Found In Mexico Is Authentic Alien
Edit WorldNews.com 20 Jul 2016
Marzulli, investigating claims about the alleged dead alien. He is shown interviewing Mexican paranormal expert Jamie Maussan.“It is a hybrid, and that is something very important, because I believe these are confidential experiments, and why I don’t know,” Maussan says in the video. “But we have a physical body ... The scientist claims X-ray investigation shows the alleged alien corpse is not a hoax.“It has wings....
photo: AP / Andrew Harnik
Supermodel Miranda Kerr Is Engaged to Snapchat Billionaire Evan Spiegel
Edit Forbes 20 Jul 2016
Victoria's Secret model Miranda Kerr announced her engagement to Snapchat CEO Evan Spiegel Wednesday with a photo of a sizable ring and, naturally, a custom Snapchat filter. I said yes!!! ❤️❤️❤️ A photo posted by Miranda (@mirandakerr) on Jul 20, 2016 at 8.39am PDT The proposal, chronicledin bitmoji, came [...] ... ....
photo: AP / Adam Schreck
Massive blaze engulfs Dubai skyscraper
Edit Press TV 20 Jul 2016
A massive blaze broke out at a 75-story residential tower in a densely populated area of Dubai in the United Arab Emirates (UAE) Wednesday, sending plumes of smoke into the air and causing panic among residents. Media reports said the blaze engulfed the Sulafa Tower in the upscale Marina district. Local residents said the fire appeared to have started on the 35th floor and quickly spread to other floors ... (AP photo) ... (AP Photo) ... ....
« back to news headlines
Drug to 30 eye patients: PGI submits report to Drug Controller General
Edit Indian Express 17 Jul 2016
A statement issued on Friday by the hospital had termed the incident as “unfortunate” “…incidence of increased intraocular inflammation following intravitreal injection Avastin that was given to 30 patients on July 12 has been noticed,” the statement said.The PGI stated that three patients reported to the Advanced Eye Centre on the next day and “increased intraocular inflammation” was found after examination....
Adverum Biotechnologies Provides wet AMD Program Update (Avalanche Biotechnologies Inc)
Edit Public Technologies 07 Jul 2016
(Source. Avalanche Biotechnologies Inc). MENLO PARK, Calif., July 07, 2016 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc ... This development work, focusing on intravitreal delivery and utilizing a proprietary vector, will supersede advancement of the company's earlier product candidates, AVA-101 and AVA-201. The company also announced that its founder and chairman Mark S ... CEST ... About Adverum Biotechnologies, Inc ... Contact. Adverum ... (noodl....
Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031
Edit Stockhouse 07 Jul 2016
Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031. Eleven entitled to receive $22.5 million milestone payment for IND effectiveness. Eleven Biotherapeutics, Inc. (NASDAQ ... As a result of the achievement of this milestone, Eleven is entitled to receive a $22.5 million payment from F ... EBI-031 was designed and engineered for intravitreal delivery using Eleven’s AMP-Rx platform....
Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031 (Eleven Biotherapeutics Inc)
Edit Public Technologies 07 Jul 2016
(Source. Eleven Biotherapeutics Inc) 75d433fe-13d2-46d9-b0b5-63d3ec0e1c3d.pdf. July 7, 2016 Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031. Eleven entitled to receive $22.5 million milestone payment for IND effectiveness. CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Eleven Biotherapeutics, Inc. (NASDAQ ... EBI-031 was designed and engineered for intravitreal delivery using Eleven's AMP-Rx platform....
pSivida Announces Successful Completion of Two Preclinical Studies of Durasert™ Sustained-Release Insert Delivering Repurposed Cancer Drug to Treat Wet AMD (pSivida Corp)
Edit Public Technologies 05 Jul 2016
AMD, the leading cause of vision loss in people over 65, is most commonly treated with intravitreal injections of biologics that block the VEGF molecules that are a factor in the abnormal sub-retinal blood vessel growth leading to the disease ... AMD biologic followed by an intravitreal injection of a VEGF, which was repeated after weeks 2 and 4....
Santen Receives Positive Recommendation from CDSCO for Sirolimus (Santen Pharmaceutical Co Ltd)
Edit Public Technologies 04 Jul 2016
(Osaka, Japan) announced today that the Subject Expert Committee (SEC) of the India Central Drugs Standard Control Organization (CDSCO) has issued a positive recommendation for the import and marketing of Sirolimus 22mg/mL intravitreal solution for the chronic treatment of non-infectious uveitis of the posterior segment (NIU-PS) of the eye....
'Pain in eyes has reduced, but yet to regain vision'
Edit The Times of India 30 Jun 2016
Coimbatore. An air of gloom and uncertainty was palpable in the wards of the private hospital in the city where A Mumtaj was admitted. Mumtaj, 56, was one of the 16 villagers who lost her vision after undergoing the free cataract surgery at Mettur government hospital earlier this month ... "The pain has come down ... The patients are still being continued on antibiotic drops and Intravitreal Antibiotic injections, he said ... RELATED....
Knights Templar Eye Foundation grant supports UofL research for improved retinoblastoma treatment Nanoparticle encapsulation... (University of Louisville)
Edit Public Technologies 29 Jun 2016
(Source. University of Louisville) ... Ramasubramanian, a pediatric ophthalmologist and ocular oncologist, and Steinbach-Rankins, a professor of bioengineering at the UofL J.B. Speed School of Engineering, are developing nanoparticles that will encapsulate the drug melphalan for use in intravitreal injections in the treatment of retinoblastoma. Retinoblastoma is the most common type of eye cancer in children ... 'The work Dr ... (noodl. 34326697) ....
Knights Templar Eye Foundation, Inc., grant supports UofL research for improved retinoblastoma treatment Nanoparticle... (University of Louisville)
Edit Public Technologies 28 Jun 2016
(Source. University of Louisville) ... Ramasubramanian, a pediatric ophthalmologist and ocular oncologist, and Steinbach-Rankins, a professor of bioengineering at the UofL J.B. Speed School of Engineering, are developing nanoparticles that will encapsulate the drug melphalan for use in intravitreal injections in the treatment of retinoblastoma. Retinoblastoma is the most common type of eye cancer in children ... 'The work Dr ... (noodl. 34304910) ....
6/13/16 - Aerpio Therapeutics Reports Peer-Reviewed Publication of Positive Clinical Results from the Phase 2a Study of Lead Candidate, AKB-9778, in Diabetic Macular Edema (DME): The TIME-2 Trial (Aerpio Therapeutics Inc)
Edit Public Technologies 28 Jun 2016
(Source ... The TIME-2 Trial. Results from the TIME-2 study have been published in Ophthalmology, the journal of the American Academy of Ophthalmology ... 0.3 mg intravitreally) provided a clinically significant benefit in reduction of macular edema, as measured by central subfield thickness (CST), compared to Lucentis® alone at month 2 (p=0.02) and at end of treatment at month 3 (p=0.008) ... Steve Pakola, Aerpio's Chief Medical Officer. Dr ... DME....
Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement
Edit Stockhouse 15 Jun 2016
--KalVista to become a wholly owned subsidiary of Carbylan, and KalVista shareholders to become majority owners of Carbylan upon the closing of the transaction. PALO ALTO, Calif ... Conference Call Information ... KalVista’s most advanced program, an intravitreally administered plasma kallikrein inhibitor for DME, has successfully completed Phase 1 clinical trials in DME patients and is being prepared for a Phase 2 clinical trial ... ....
Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement (Carbylan Therapeutics Inc)
Edit Public Technologies 15 Jun 2016
(Source. Carbylan Therapeutics Inc) ... --KalVista to become a wholly owned subsidiary of Carbylan, and KalVista shareholders to become majority owners of Carbylan upon the closing of the transaction. PALO ALTO, Calif ... KalVista's most advanced program, an intravitreally administered plasma kallikrein inhibitor for DME, has successfully completed Phase 1 clinical trials in DME patients and is being prepared for a Phase 2 clinical trial....
Eleven Biotherapeutics Announces Investigational New Drug Application Submission to Initiate Clinical Trials of EBI-031 for ...
Edit Stockhouse 13 Jun 2016
Eleven Biotherapeutics Announces Investigational New Drug Application Submission to Initiate Clinical Trials of EBI-031 for Ocular Diseases. Eleven Biotherapeutics, Inc. (NASDAQ ... “We are pleased to have this IND under review by the FDA,” said Abbie Celniker, Ph.D., President and Chief Executive Officer of Eleven Biotherapeutics ... EBI-031 was designed and engineered for intravitreal delivery using Eleven’s AMP-Rx platform....
- 1
- 2
- 3
- 4
- 5
- Next page »
